Actively Recruiting
Target-specific immunoPET Imaging of Digestive System Carcinoma
Led by RenJi Hospital · Updated on 2025-12-31
400
Participants Needed
1
Research Sites
143 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to establish and optimize the target-specific PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agents in digestive system malignant tumors will be evaluated.
CONDITIONS
Official Title
Target-specific immunoPET Imaging of Digestive System Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 to 75 years old, any gender
- Histologically confirmed or suspected digestive system carcinoma by imaging
- Able to provide signed informed consent and follow study requirements
You will not qualify if you...
- Pregnant
- Severe liver or kidney problems
- History of serious surgery in the last month
- Allergic to antibody or single-domain antibody radiopharmaceuticals
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China, 200127
Actively Recruiting
Research Team
W
Weijun Wei, Ph.D. & M.D.
CONTACT
S
Shuxian An, Ph.D. & M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here